DVA vs XBIO · P/E 14, rev $6.97B vs rev $1.5M
DaVita HealthCare Partners Inc (DVA) versus Xenetic Biosciences Inc (XBIO) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Xenetic Biosciences Inc (XBIO) is a biotechnology company listed on US.
Latest reported DVA revenue for 2026-06-30 was $6.97B. Net income was $462.9M. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported XBIO revenue for 2026-06-30 was $1.5M. Net income was -$1.4M. Revenue was up 81.9% from 2026-03-31 to 2026-06-30. XBIO currently screens at market cap $5.7M.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. XBIO currently screens at market cap $5.7M.
Not investment advice. Open the DVA and XBIO stock pages for the full models.
Not investment advice.